• Duphat 2026 MedEdge MEA
  • Dubai Derma 2026 DWTC
  • GHE Riyadh 2026 MedEdge
MedEdge MEA

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
  • Her Health
Reading: Illumina appoints Everett Cunningham as Chief Commercial Officer
Share
Notification
  • Duphat 2026 MedEdge MEA
  • Dubai Derma 2026 DWTC
  • GHE Riyadh 2026 MedEdge
MedEdge MEA logo full
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
  • Her Health
Have an existing account? Sign In

Home - Personnel - Illumina appoints Everett Cunningham as Chief Commercial Officer

PersonnelNews

Illumina appoints Everett Cunningham as Chief Commercial Officer

ME Desk
ME Desk
Published: June 5, 2024
Share
2 Min Read
Illumina appoints Everett Cunningham as Chief Commercial Officer
SHARE
google_preferred_source_badge_light_en@2x

SAN DIEGO- June, 2024- Illumina announced the appointment of Everett Cunningham as Chief Commercial Officer (CCO), effective June 10.

Illumina, Inc., announced the appointment of Everett Cunningham as Chief Commercial Officer, effective June 10. Cunningham will be responsible for building, guiding, and managing the companyโ€™s global commercial organization. Most recently, Cunningham served as Chief Commercial Officer at Exact Sciences.

Moreover, Cunningham will be responsible for building, guiding, and managing the company’s global commercial organization. He brings extensive commercial experience across the healthcare tech, life sciences, and pharmaceutical industries. Most recently, Cunningham served as Chief Commercial Officer at Exact Sciences, where he oversaw the company’s marketing, sales, and customer service functions. Prior to Exact Sciences, he held various senior leadership roles at Quest Diagnostics, GE Healthcare, and Pfizer, where he spent 21 years as a commercial leader.

Cunningham has a demonstrated track record of success in driving operational excellence, delivering top-line results, and expanding into new markets. He effectively leads teams through transformational change to better serve customers, earning recognition as a strong leader.

Also Read: Mayo Clinic names new Department of Neurosurgery chair in Rochester

“I am thrilled to welcome Everett to the Illumina leadership team as we work to deliver on Illumina’s mission to improve human health by unlocking the power of the genome,” said Jacob Thaysen, Illumina CEO. “He brings tremendous commercial leadership experience to the role, along with a passion for solving some of the world’s most pressing healthcare challenges. I am looking forward to seeing all that he and our global commercial teams can do together, capitalizing on our leadership position in next generation sequencing, and delivering the products, services, and solutions that address customers’ most pressing needs.”

Furthermore, Cunningham will be relocating to San Diego. He succeeds Bas Verhoef, interim CCO and Head of Region, Europe, since January 2024. Verhoef will continue as Head of Region for Europe beginning June 10.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article UF Health St. Johns appoints new executives UF Health St. Johns appoints new executives
Next Article Lilly, UNICEF expand support to help millions of young people at risk of NCDs Lilly, UNICEF expand support to help millions of young people at risk of NCDs

Recent Posts

  • UAE Performs Middle East’s First Advanced Spinal Stabilisation Procedure
  • Al Ain Opens First Integrated Urgent Care Center at Day Surgery Facility
  • 3,333km Endurance Ride Raises AED 2.4 Million for Cancer Care
  • Dubai to Launch Longevity AI Research Lab in Q4 2026
  • Egypt Expands Fertility Tourism with New Healthcare Investments
  • DERMA
  • Global Health Riyadh 2026 MedEdge MEA
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Illumina appoints Everett Cunningham as Chief Commercial Officer
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Illumina appoints Everett Cunningham as Chief Commercial Officer
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?